HTHT
MRNA icon

Hemenway Trust Hemenway Trust’s Moderna MRNA Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,466
Closed -$566K – 128
2024
Q3 		$566K Buy
8,466
+1,188
+16% +$109K 0.04% 81
2024
Q2 		$864K Buy
7,278
+35
+0.5% +$4.43K 0.07% 68
2024
Q1 		$772K Buy
7,243
+1,213
+20% +$122K 0.07% 74
2023
Q4 		$600K Buy
6,030
+2,245
+59% +$189K 0.06% 78
2023
Q3 		$391K Sell
3,785
-325
-8% -$36.3K 0.04% 100
2023
Q2 		$499K Buy
4,110
+2,341
+132% +$312K 0.05% 96
2023
Q1 		$272K Buy
+1,769
New +$292K 0.03% 115

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Hemenway Trust Hemenway Trust's MRNA Position: Q4 2024 in Review

Hemenway Trust Hemenway Trust sold out of Moderna (MRNA) in Q4 2024, closing a stake of 8,466 shares — an estimated $566K sold.

Hemenway Trust Hemenway Trust first reported a position in MRNA in Q1 2023 and held it in 7 quarters. The position peaked at $864K in Q2 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Hemenway Trust Hemenway Trust reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Hemenway Trust Hemenway Trust sold 8,466 Moderna shares in Q4 2024, an estimated $566K.
  • Hemenway Trust Hemenway Trust first reported a position in Moderna in Q1 2023 and held it in 7 quarters.
  • Hemenway Trust Hemenway Trust's Moderna position peaked at $864K in Q2 2024.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q4 2024, filed 13 Feb 2025.